Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015

被引:36
作者
Lei, Jiayao [1 ]
Balakrishnan, Madhava Ram [2 ]
Gidudu, Jane F. [3 ]
Zuber, Patrick L. F. [2 ]
机构
[1] Karolinska Inst, Stockholm, Sweden
[2] WHO, Geneva, Switzerland
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
Global vaccine safety blueprint; Global vaccine action plan; Adverse events following immunization; AEFI reporting; Vaccine safety surveillance; PERSPECTIVE; CAPACITY; TRIAL; CHINA; AEFI;
D O I
10.1016/j.vaccine.2018.02.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reporting of adverse events following immunization (AEFI) is a key component for functional vaccine safety monitoring system. The aim of our study is to document trends in the AEFI reporting ratio globally and across the six World Health Organization (WHO) regions. We describe the number of AEFI reports communicated each year through the World Health Organization/United Nations Children's Fund Joint Reporting Form on Immunization from 2000 to 2015. The AEFI reporting ratios (annual AEFI reports per 100,000 surviving infants) were calculated to identify WHO countries (n = 191 in 2000 and n = 194 by 2015) that met a minimal reporting ratio of 10, a target set by the Global Vaccine Action Plan for vaccine safety monitoring as a proxy measure for a functional AEFI reporting system. The number of countries reporting any AEFI fluctuated over time but with progress from 32 (17%) in 2000 to 124 (64%) in 2015. In 2015, the global average AEFI reporting ratio was 549 AEFI reports per 100,000 surviving infants. The number of countries with AEFI reporting ratios greater than 10 increased from 8 (4%) in 2000 to 81 (42%) in 2015. In 2015, 60% of countries in the WHO Region of the Americas reported at least 10 AEFI per 100,000 surviving infants, followed by 55% in European Region, 43% in Eastern Mediterranean Region, 33% in Western Pacific Region, 27% in South-East Asia Region and 21% in African Region. Overall, AEFI reporting has increased over the past sixteen years worldwide, but requires strengthening in a majority of low- and middle-income countries. The AEFI reporting ratio is useful for benchmarking and following trends over time; but does not provide information on the quality of the reporting system and does not guarantee capacity to detect and manage a vaccine safety problem at a national level. Additional efforts are required to ensure and improve data quality, AEFI reporting and surveillance of immunization safety in every country. (C) 2018 World Health Organization; licensee Elsevier Ltd.
引用
收藏
页码:1577 / 1582
页数:6
相关论文
共 20 条
  • [1] Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization
    Amarasinghe, Ananda
    Black, Steve
    Bonhoeffer, Jan
    Carvalho, Sandra M. Deotti
    Dodoo, Alexander
    Eskola, Juhani
    Larson, Heidi
    Shin, Sunheang
    Olsson, Sten
    Balakrishnan, Madhava Ram
    Bellah, Ahmed
    Lambach, Philipp
    Maure, Christine
    Wood, David
    Zuber, Patrick
    Akanmori, Bartholomew
    Bravo, Pamela
    Pombo, Maria
    Langar, Houda
    Pfeifer, Dina
    Guichard, Stephane
    Diorditsa, Sergey
    Hossain, Md. Shafiqul
    Sato, Yoshikuni
    [J]. VACCINE, 2013, 31 : B108 - B114
  • [2] [Anonymous], 2014, Global Manual on Surveillance of Adverse Events Following Immunization
  • [3] [Anonymous], 2015, PERF IND VACC SAF MO
  • [4] [Anonymous], 2015 REV WORLD POP P
  • [5] [Anonymous], 2015, Global Advisory Committee on Vaccine Safety: Statement on Safety of HPV vaccines
  • [6] [Anonymous], 2009, STAT WORLDS VACC IMM
  • [7] Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): A randomized controlled trial
    Ateudjieu, Jerome
    Stoll, Beat
    Nguefack-Tsague, Georges
    Tchangou, Christoph
    Genton, Blaise
    [J]. VACCINE, 2014, 32 (43) : 5662 - 5668
  • [8] CDC, 1999, WITHDR ROT VACC REC
  • [9] Enhancing vaccine safety capacity globally: A lifecycle perspective
    Chen, Robert T.
    Shimabukuro, Tom T.
    Martin, David B.
    Zuber, Patrick L. P.
    Weibel, Daniel M.
    Sturkenboom, Miriam
    [J]. VACCINE, 2015, 33 : D46 - D54
  • [10] Capacity for a global vaccine safety system: The perspective of national regulatory authorities
    Graham, Janice E.
    Borda-Rodriguez, Alexander
    Huzair, Farah
    Zinck, Emily
    [J]. VACCINE, 2012, 30 (33) : 4953 - 4959